Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
21 February 2014 09:50
Clinical trials were carried out in vivo as well as in vitro
A new drug which selectively kills dormant cancer cells has been tested by scientists.
The molecule works by inducing dysfunction in mitochondria - the powerhouse of cells.
The research, conducted by Prof Stig Linder of the Swedish Karolinska Instituet and Uppsala University, found that a small molecule named VLX600 has been proven ineffective in killing dormant colon cancer cells in a variety of models, including in clinical trials and in test subjects with the medical condition.
Experts say that in solid tumours larger than a few millimetres, a lack of oxygen and nutrients is common as a result of insufficient growth in the blood vessels. This can cause cancer cells to remain dormant - and even after they receive treatment, they can divide, causing tumours to grow. This process helps cancers resist radiotherapy and chemotherapy.
The study shows that in these tumour areas that lack oxygen and nutrition, there is a lack of mitochondrial energy production for which the cancer cells cannot compensate. The researchers said: "Our ?ndings suggest that tumour cells in nutritionally compromised microenvironments are sensitive to disturbances of mitochondrial function, resulting in a bioenergetic catastrophe."
The VLX600 molecule was found to cause this dysfunction in mitochondria, causing colon cancer cells to die. When the substance was tested on colon cancer cell lines in vivo, it suppressed tumour growth. The molecule also helped boost other anti-cancer drugs, such as irinotecan.
The study leaders said: "Our ?ndings suggest that tumour cells in metabolically compromised microenvironments have a limited ability to respond to decreased mitochondrial function, and suggest a strategy for targeting the quiescent populations of tumour cells for improved cancer treatment."
People can find more information about travel insurance for cancer patients here.
19 February 2019
Hundreds of passengers have had their travel plans cancelled following the collapse of airline flybmi.
[more...]
16 February 2019
Holidaymakers were left fuming after a "lack of clarity" over Brexit led a Romanian airline to cancel flights from Liverpool's John Lennon Airport.
15 February 2019
British Airways celebrated Valentine's Day with a special flight where all members of the cabin crew were couples who work for the airline.
14 February 2019
The "concerning" level of stigma surrounding the human papilloma virus (HPV) could be putting some women off going for vital check-ups, campaigners are warning.
13 February 2019
Older people living with depression should be given better access to community activities and therapy instead of being prescribed antidepressants, researchers have urged.
12 February 2019
The Government has been criticised for failing to act on warnings about the link between processed meats and cancer, by the scientist who co-authored the original advice.
09 February 2019
A grandfather who has battled three types of cancer is cycling from Twickenham to Tokyo in time for the Rugby World Cup - all in aid of charity.
08 February 2019
Lovers of traditional fish and chips are embracing a more health-conscious version of their favourite food, a new study suggests.
07 February 2019
Two thirds of UK adults don't know they're able to lower their risk of developing dementia, new research has shown.
06 February 2019
More than 600 people a day are quitting their jobs to care for relatives, a charity has warned.
05 February 2019
Millennials in the US face an increasing risk of developing an obesity-related cancer, a new study has revealed.
02 February 2019
More than 100 people sought refuge at a pub high on Bodmin Moor overnight after heavy snowfall hit the A30, leading many stranded motorists to abandon their cars.